Verici DX (VRCI)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

0.63p
   
  • Change Today:
    -0.050p
  • 52 Week High: 5.75
  • 52 Week Low: 0.52
  • Currency: UK Pounds
  • Shares Issued: 1,513.39m
  • Volume: 4,636,332
  • Market Cap: £9.46m
  • RiskGrade: 429
  • Beta: 3.07

Deal with Barclays    Trade now with Barclays Stockbrokers

Verici DX Overview

Verici was incorporated in April 2020 as a wholly-owned subsidiary of Renalytix AI plc ("RENX"), the AIM-quoted developer of artificial intelligence decision support and clinical management tools for improving early diagnosis, continual monitoring and drug development for kidney disease. The Company develops tests to understand how a patient is likely and may be responding to kidney transplant.
Competitors: ValiRx, e-Therapeutics, Genflow Biosciences , Oxford Biodynamics

Key Personnel

CEO: Sara Barrington
Non-Executive Chairman: Julian Baines
Senior Independent Non-Executive Director: Ian James Carruthers
Non-Executive Dir: Lorenzo Gallon, Aubrey Powell, James Renwick McCullough

Contact Details

Address: Avon House, 19 Stanwell Road, Penarth, Cardiff, United Kingdom, CF64 2EZ
Phone: +44 (0)29 2071 0570
Website: http://www.vericidx.com/

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share
ISIN: GB00BM8HZD43

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Verici DX Market Data

Currency UK Pounds
Share Price 0.63p
Change Today -0.050p
% Change -7.41 %
52 Week High 5.75
52 Week Low 0.52
Volume 4,636,332
Shares Issued 1,513.39m
Market Cap £9.46m
Beta 3.07
RiskGrade 429

Verici DX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
32.71% below the market average32.71% below the market average32.71% below the market average32.71% below the market average32.71% below the market average
12.2% below the sector average12.2% below the sector average12.2% below the sector average12.2% below the sector average12.2% below the sector average
Price Trend
97.82% below the market average97.82% below the market average97.82% below the market average97.82% below the market average97.82% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Income Not Available
Growth
25.52% above the market average25.52% above the market average25.52% above the market average25.52% above the market average25.52% above the market average
10.34% above the sector average10.34% above the sector average10.34% above the sector average10.34% above the sector average10.34% above the sector average

Verici DX Dividends

No dividends found

Trades for 04-Nov-2025

Time Volume / Share Price
15:38 883,486 @ 0.63p
15:07 500,000 @ 0.61p
15:05 43,000 @ 0.64p
14:10 154 @ 0.65p
13:44 750,000 @ 0.61p

Verici DX Key Personnel

CEO Sara Barrington

Top of Page